Labquality 1261 Haemoglobin A1c, Liquid Samples (Not
Suitable for Afinion Instrument) Exam – Comprehensive
Practice Assessment
Overview
This comprehensive 300-question practice assessment is designed to prepare candidates for
the Labquality 1261 Haemoglobin A1c, Liquid Samples (Not Suitable for Afinion Instrument)
external quality assessment (EQA) scheme. Labquality Scheme 1261 is an external quality
assessment programme for HbA1c testing using liquid whole blood samples. It is part of the
Clinical Chemistry EQA portfolio and is designed to assess laboratory performance in HbA1c
analysis, covering analytical performance, quality control, result interpretation, and clinical
applications of HbA1c testing .
The scheme is accredited by FINAS (PT02) based on ISO/EN 17043 and is operated six times
per year with two fresh whole blood samples of 0.5 mL each. Results are processed in IFCC
units . The liquid samples used in this scheme are not suitable for the Afinion instrument due to
sample matrix incompatibility .
Exam Specifications:
| Parameter | Detail |
|--|--|
| Scheme Number | 1261 |
| Sample Type | Liquid whole blood (0.5 mL per sample) |
| Samples per Round | 2 |
| Rounds per Year | 6 |
| Storage Condition | Refrigerated at 2–8°C, analyse promptly |
| Reporting Units | IFCC (mmol/mol) and NGSP/DCCT (%) |
| Accreditation | FINAS PT02, ISO/IEC 17043:2023 |
Exam Domains and Weighting
| Domain | Percentage |
|--||
| Scheme Overview & Labquality Framework | 10% |
| Analytical Performance & Method Evaluation | 15% |
| Quality Control & Internal Quality Assurance | 15% |
| Result Interpretation & Clinical Application | 20% |
| HbA1c Standardization (IFCC/NGSP/DCCT) | 15% |
| Methodology & Analytical Principles | 10% |
| Interferences & Limitations | 10% |
,| Reporting Units & Result Entry | 5% |
Section 1: Scheme Overview & Labquality Framework (Questions 1-30)
Question 1
What is the primary purpose of Labquality Scheme 1261?
A) To certify laboratory directors
B) To provide external quality assessment for HbA1c testing using liquid samples
C) To provide clinical diagnosis of diabetes
D) To replace internal quality control
Answer: B) To provide external quality assessment for HbA1c testing using liquid samples
Rationale: Labquality Scheme 1261 is an external quality assessment (EQA) scheme for
Haemoglobin A1c testing using liquid samples. It is part of the Clinical Chemistry EQA portfolio
and is designed to assess laboratory performance in HbA1c analysis .
Question 2
Why are the samples in Scheme 1261 described as "not suitable for Afinion instrument"?
A) The samples are too viscous
B) The sample matrix is incompatible with the Afinion instrument
C) The samples are frozen
D) The samples are too dilute
Answer: B) The sample matrix is incompatible with the Afinion instrument
Rationale: The liquid whole blood samples used in the Labquality HbA1c scheme are
specifically noted as not suitable for the Afinion instrument due to sample matrix incompatibility.
The Afinion instrument requires a different sample type or matrix for accurate HbA1c
measurement .
Question 3
What is the typical volume of each liquid HbA1c sample in Labquality Scheme 1261?
A) 0.1 mL
B) 0.5 mL
C) 1.0 mL
,D) 2.0 mL
Answer: B) 0.5 mL
Rationale: The liquid whole blood samples used in the Labquality HbA1c scheme are typically
0.5 mL per sample. This volume is sufficient for most HbA1c analytical methods .
Question 4
What is the recommended storage condition for the liquid HbA1c samples before analysis?
A) Room temperature
B) Refrigerated at 2–8°C
C) Frozen at -20°C
D) Incubated at 37°C
Answer: B) Refrigerated at 2–8°C
Rationale: Liquid whole blood samples for HbA1c testing should be stored refrigerated at 2–8°C
and analyzed promptly to ensure sample integrity and accurate results .
Question 5
How many rounds of the Labquality HbA1c scheme are conducted per year?
A) 2
B) 4
C) 6
D) 12
Answer: C) 6
Rationale: Labquality Scheme 1261 is operated six times per year, with two fresh whole blood
samples distributed each round .
Question 6
What accreditation does Labquality Scheme 1261 hold?
A) ISO 9001
B) ISO/IEC 17043:2023
, C) ISO 15189
D) ISO 13485
Answer: B) ISO/IEC 17043:2023
Rationale: Labquality Scheme 1261 is accredited by FINAS (PT02) based on ISO/IEC
17043:2023, the international standard for proficiency testing providers .
Question 7
What is the target group for Labquality Scheme 1261?
A) Only hospital laboratories
B) Laboratories and POCT units
C) Only research laboratories
D) Only physician offices
Answer: B) Laboratories and POCT units
Rationale: The scheme is designed for laboratories and point-of-care testing (POCT) units in
Europe and the Middle East that perform HbA1c testing .
Question 8
What is the Finnish term for Clinical Chemistry, which indicates the section of Labquality's EQA
portfolio that includes HbA1c?
A) KLIININEN KEMIA
B) HEMOGLOBIINI
C) MOLEKULAARINEN
D) MIKROBIOLOGIA
Answer: A) KLIININEN KEMIA
Rationale: "KLIININEN KEMIA" is Finnish for "Clinical Chemistry," indicating that the HbA1c
scheme falls under the clinical chemistry section of Labquality's EQA portfolio .
Question 9
What is the role of the scheme coordinator for the Labquality HbA1c scheme?
Suitable for Afinion Instrument) Exam – Comprehensive
Practice Assessment
Overview
This comprehensive 300-question practice assessment is designed to prepare candidates for
the Labquality 1261 Haemoglobin A1c, Liquid Samples (Not Suitable for Afinion Instrument)
external quality assessment (EQA) scheme. Labquality Scheme 1261 is an external quality
assessment programme for HbA1c testing using liquid whole blood samples. It is part of the
Clinical Chemistry EQA portfolio and is designed to assess laboratory performance in HbA1c
analysis, covering analytical performance, quality control, result interpretation, and clinical
applications of HbA1c testing .
The scheme is accredited by FINAS (PT02) based on ISO/EN 17043 and is operated six times
per year with two fresh whole blood samples of 0.5 mL each. Results are processed in IFCC
units . The liquid samples used in this scheme are not suitable for the Afinion instrument due to
sample matrix incompatibility .
Exam Specifications:
| Parameter | Detail |
|--|--|
| Scheme Number | 1261 |
| Sample Type | Liquid whole blood (0.5 mL per sample) |
| Samples per Round | 2 |
| Rounds per Year | 6 |
| Storage Condition | Refrigerated at 2–8°C, analyse promptly |
| Reporting Units | IFCC (mmol/mol) and NGSP/DCCT (%) |
| Accreditation | FINAS PT02, ISO/IEC 17043:2023 |
Exam Domains and Weighting
| Domain | Percentage |
|--||
| Scheme Overview & Labquality Framework | 10% |
| Analytical Performance & Method Evaluation | 15% |
| Quality Control & Internal Quality Assurance | 15% |
| Result Interpretation & Clinical Application | 20% |
| HbA1c Standardization (IFCC/NGSP/DCCT) | 15% |
| Methodology & Analytical Principles | 10% |
| Interferences & Limitations | 10% |
,| Reporting Units & Result Entry | 5% |
Section 1: Scheme Overview & Labquality Framework (Questions 1-30)
Question 1
What is the primary purpose of Labquality Scheme 1261?
A) To certify laboratory directors
B) To provide external quality assessment for HbA1c testing using liquid samples
C) To provide clinical diagnosis of diabetes
D) To replace internal quality control
Answer: B) To provide external quality assessment for HbA1c testing using liquid samples
Rationale: Labquality Scheme 1261 is an external quality assessment (EQA) scheme for
Haemoglobin A1c testing using liquid samples. It is part of the Clinical Chemistry EQA portfolio
and is designed to assess laboratory performance in HbA1c analysis .
Question 2
Why are the samples in Scheme 1261 described as "not suitable for Afinion instrument"?
A) The samples are too viscous
B) The sample matrix is incompatible with the Afinion instrument
C) The samples are frozen
D) The samples are too dilute
Answer: B) The sample matrix is incompatible with the Afinion instrument
Rationale: The liquid whole blood samples used in the Labquality HbA1c scheme are
specifically noted as not suitable for the Afinion instrument due to sample matrix incompatibility.
The Afinion instrument requires a different sample type or matrix for accurate HbA1c
measurement .
Question 3
What is the typical volume of each liquid HbA1c sample in Labquality Scheme 1261?
A) 0.1 mL
B) 0.5 mL
C) 1.0 mL
,D) 2.0 mL
Answer: B) 0.5 mL
Rationale: The liquid whole blood samples used in the Labquality HbA1c scheme are typically
0.5 mL per sample. This volume is sufficient for most HbA1c analytical methods .
Question 4
What is the recommended storage condition for the liquid HbA1c samples before analysis?
A) Room temperature
B) Refrigerated at 2–8°C
C) Frozen at -20°C
D) Incubated at 37°C
Answer: B) Refrigerated at 2–8°C
Rationale: Liquid whole blood samples for HbA1c testing should be stored refrigerated at 2–8°C
and analyzed promptly to ensure sample integrity and accurate results .
Question 5
How many rounds of the Labquality HbA1c scheme are conducted per year?
A) 2
B) 4
C) 6
D) 12
Answer: C) 6
Rationale: Labquality Scheme 1261 is operated six times per year, with two fresh whole blood
samples distributed each round .
Question 6
What accreditation does Labquality Scheme 1261 hold?
A) ISO 9001
B) ISO/IEC 17043:2023
, C) ISO 15189
D) ISO 13485
Answer: B) ISO/IEC 17043:2023
Rationale: Labquality Scheme 1261 is accredited by FINAS (PT02) based on ISO/IEC
17043:2023, the international standard for proficiency testing providers .
Question 7
What is the target group for Labquality Scheme 1261?
A) Only hospital laboratories
B) Laboratories and POCT units
C) Only research laboratories
D) Only physician offices
Answer: B) Laboratories and POCT units
Rationale: The scheme is designed for laboratories and point-of-care testing (POCT) units in
Europe and the Middle East that perform HbA1c testing .
Question 8
What is the Finnish term for Clinical Chemistry, which indicates the section of Labquality's EQA
portfolio that includes HbA1c?
A) KLIININEN KEMIA
B) HEMOGLOBIINI
C) MOLEKULAARINEN
D) MIKROBIOLOGIA
Answer: A) KLIININEN KEMIA
Rationale: "KLIININEN KEMIA" is Finnish for "Clinical Chemistry," indicating that the HbA1c
scheme falls under the clinical chemistry section of Labquality's EQA portfolio .
Question 9
What is the role of the scheme coordinator for the Labquality HbA1c scheme?
